ArticleBMJ open2021

Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)-insights of people affected by cancer and healthcare professionals: a qualitative study protocol.

Stephen Jennings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.